Kyle W. Klarich

WinnMed, Mayo Clinic in Arizona

Papers

3

Total Citations

12

H-Index

2

About

Kyle W. Klarich is a leading figure in the surgical management of cardiac tumors, with a particular focus on minimally invasive and robotic-assisted techniques. His work has significantly advanced the treatment of papillary fibroelastomas (PFEs) and myxomas, demonstrating that complex cardiac tumor resections can be performed safely through less invasive approaches than traditional sternotomy. His 2012 paper on robot-assisted mitral valve PFE resection, which has accumulated 7 citations, established a foundational protocol for combining three-dimensional transesophageal echocardiography with robotic surgery to achieve excellent outcomes. More recently, his 2024 case series from the Mayo Clinic, documenting 12 patients who underwent robotic-assisted PFE resection, has already garnered 3 citations and represents one of the largest single-center experiences with this technique. Klarich’s work extends beyond PFEs; his 2024 case report of a large left atrial myxoma extending into the pulmonary veins highlights his expertise in managing complex, anatomically challenging tumors. Through these contributions, Klarich has helped define a new standard of care—proving that robotic-assisted cardiac tumor surgery can minimize patient trauma while maintaining the oncologic rigor of open procedures.

Research Focus

Key Achievements

2
H-Index
3
Papers
12
Total Citations
4
Avg Citations/Paper
🏆 Most Cited Paper
Surgical Resection of Mitral Valve Papillary Fibroelastoma: A Robot-Assisted, Minimally Invasive Approach with Three-Dimensional Transesophageal Echocardiography Imaging
7 citations · 2012
📈 Most Prolific Year: 2024 (2 Papers)
🤝 Key Collaborators: 16
🏛 Institutions: WinnMed, Mayo Clinic in Arizona

Top Papers

  1. 1
  2. 2
  3. 3

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago